Abstract
With an incidence of 5.6 / 100000, tuberculosis remains rare in Germany. However, for the first time since over 60 years, case numbers have began to increase since 2013. Therefore, knowledge of the clinical presentation as well as diagnostic and therapeutic approaches is important, specifically when caring for migrant patients. The broad use of molecular analyses will soon facilitate the choice of therapeutic regimens. Novel drugs already enable us to successfully treat also the increasing numbers of drug-resistant tuberculosis cases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
